Onkologie. 2016:10(4):193-195 | DOI: 10.36290/xon.2016.042

Risk adapted treatment in clinical stage I. non-seminomatous germ cell tumours

Tomáš Pokrivčák, Radek Lakomý, Rostislav Vyzula

Klinika komplexní onkologické péče, MOÚ Brno

The most common malignancy in men aged 15–40 years are testicular germ cell tumors. Thanks to the high sensitivity to oncology

therapy belongs to the group of highly curable oncologic diseases with favorable prognoses. Non-seminomatous germ cell

tumors represent approximately 45 % of all testicular tumors. Most of them are captured in stage I. According to the recommendations

of professional societies is the standard procedure after primarily orchiectomy inconsistent. It can be used surveillance,

cisplatin-based chemotherapy or retroperitoneal lymphadenectomy. The probability of relapse depends on risk factors. The most

important factor is the presence of lymphovascular invasion. The aim of our report is to use the following case reports to point

of necessary stratification which can lead to minimize side effects with maintaining the minimum number of relapses.

Keywords: testicular cancer, non-seminomatous germ cell tumors, adjuvant chemotherapy, surveillance

Published: August 1, 2016  Show citation